Language

News topic

Product CAELYX

Current shortage notices for the product family CAELYX, structured by product, country and reporting period.

5 notices

← All shortages

Belgium

Caelyx Pegylated Liposomal 2 mg/ml inf. sol. (conc.) i.v. vial 10 ml

Active ingredient: Doxorubicin Hydrochloride

View notice details →
Belgium

Caelyx Pegylated Liposomal 2 mg/ml inf. sol. (conc.) i.v. vial 25 ml

Active ingredient: Doxorubicin Hydrochloride

View notice details →
Austria

Caelyx 2 mg/ml Konzentrat zur Herstellung einer Infusionslösung

Active ingredient: DOXORUBICIN HYDROCHLORID

View notice details →
Belgium

Caelyx Pegylated Liposomal 2 mg/ml inf. opl. (conc.) i.v. flac. 25 ml

Active ingredient: Doxorubicin Hydrochloride

View notice details →
Czechia

CAELYX PEGYLATED LIPOSOMAL 2MG/ML INF CNC SOL 1X10ML

Active ingredient: DOXORUBICIN

View notice details →